<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine whether <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> increases the risk of <z:mp ids='MP_0002830'>gallstone</z:mp> formation in children with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1263988" disease_type="Disease or Syndrome" abbrv="">hemolytic disease</z:e>, we studied 44 children with this diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001081'>Gallstones</z:hpo> were detected by abdominal ultrasonography </plain></SENT>
<SENT sid="2" pm="."><plain>This took place annually in scheduled examinations or in the context of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, the mean values of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, reticulocyte and serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase were recorded </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, TA insertion in the A(TA)nTATAA motif within the promoter region of the enzyme <z:chebi fb="0" ids="17659">uridine-diphosphate</z:chebi>-glucuronyl transferase (UGT1A1) was screened, since this is typically associated with GS.We found 10 (22.7 %) homozygotes for the mutated allele TA*7/TA*7, 12 (27.3 %) TA*6/TA*6 heterozygotes and 22 (50 %) homozygotes for the <z:mp ids='MP_0002169'>wild-type</z:mp> allele TA*6/TA*6 </plain></SENT>
<SENT sid="5" pm="."><plain>No statistically significant differences were found in the values of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (Kruskal-Wallis test 2.496; p &gt; 0.05) or in reticulocyte count (Kruskal-Wallis test 1.696; p &gt; 0,05) between the three groups of patients, suggesting a similar degree of <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with the UGT1A1 TA*7/TA*7 genotype showed higher mean serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels than did patients who were homozygous for the <z:mp ids='MP_0002169'>wild-type</z:mp> allele (Mann-Whitney test 35.5; p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>None of the patients with the TA*6/TA*6 genotype developed <z:hpo ids='HP_0001081'>gallstones</z:hpo>, whereas this complication was found in 2 of 12 (16.6 %) heterozygotes and 6 of 10 (60 %) homozygotes for the allele with TA insertion </plain></SENT>
<SENT sid="8" pm="."><plain>In this latter group, 4 patients presented <z:hpo ids='HP_0001735'>acute pancreatitis</z:hpo> as a consequence of <z:mp ids='MP_0002830'>gallstone</z:mp> formation.The association between <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> load due to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1263988" disease_type="Disease or Syndrome" abbrv="">hemolytic disease</z:e> and diminished hepatic conjugation leads to raised serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels and consequently to an increased risk of <z:mp ids='MP_0002830'>gallstone</z:mp> formation </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, we recommend screening for <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in children in the initial phases of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1263988" disease_type="Disease or Syndrome" abbrv="">hemolytic diseases</z:e> </plain></SENT>
</text></document>